| Trial ID: | L1412 |
| Source ID: | NCT00108485
|
| Associated Drug: |
Extended Release Niacin
|
| Title: |
Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00108485/results
|
| Conditions: |
Diabetes Mellitus, Type 2|Kidney Failure, Chronic|Hyperlipidemia
|
| Interventions: |
DRUG: Extended release niacin|OTHER: Placebo
|
| Outcome Measures: |
Primary: Change in Proteinuria, Baseline, 1 year |
|
| Sponsor/Collaborators: |
Sponsor: University of Miami
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
9
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-04
|
| Completion Date: |
2012-12
|
| Results First Posted: |
2016-05-12
|
| Last Update Posted: |
2016-06-22
|
| Locations: |
Univesity of Miami/Diabetes Research Institute, Miami, Florida, 33136, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00108485
|
